Company intelligence / Profile preview

Kindred Ventures

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Kindred Ventures is an active U.S.-based seed-stage venture capital firm that backs early-stage companies across technology- and science-driven sectors. The firm invests broadly rather than operating as a drug developer, with areas of interest spanning AI, consumer technology, fintech, climate, crypto/web3, mobility, and health and wellness. In healthcare, Kindred appears to focus mainly on digital health, health AI, and tech-enabled care delivery through portfolio investments rather than building its own therapeutic pipeline. The firm was founded in 2014 and is led by Steve Jang and Kanyi Maqubela. For biotech analyst purposes, this is an investor, not a biotech/pharma operating company.

Industry: Investors

Beyond the preview

Go deeper on Kindred Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kindred Ventures.

Explore the full profile